From animal models to gut-on-chip: the challenging journey to capture inter-individual variability in chronic digestive disorders
ABSTRACTChronic digestive disorders are of increasing incidence worldwide with expensive treatments and no available cure. Available therapeutic schemes mainly rely on symptom relief, with large degrees of variability in patients’ response to such treatments, underlining the need for new therapeutic...
Main Authors: | Aicha Kriaa, Vincent Mariaule, Charlotte De Rudder, Amin Jablaoui, Harry Sokol, Paul Wilmes, Emmanuelle Maguin, Moez Rhimi |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Gut Microbes |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19490976.2024.2333434 |
Similar Items
-
Bile Salt Hydrolases: At the Crossroads of Microbiota and Human Health
by: Mélanie Bourgin, et al.
Published: (2021-05-01) -
Gut Serpinome: Emerging Evidence in IBD
by: Héla Mkaouar, et al.
Published: (2021-06-01) -
The Nexus of Diet, Gut Microbiota and Inflammatory Bowel Diseases in Dogs
by: Soufien Rhimi, et al.
Published: (2022-11-01) -
SP-1, a Serine Protease from the Gut Microbiota, Influences Colitis and Drives Intestinal Dysbiosis in Mice
by: Aicha Kriaa, et al.
Published: (2021-10-01) -
Bile Acids: Key Players in Inflammatory Bowel Diseases?
by: Aicha Kriaa, et al.
Published: (2022-03-01)